1. Short title This Act may be cited as the Royalty Transparency Act . 2. Financial disclosure reports of executive branch employees (a) Individuals required To file (1) In general Section 13103 of title 5, United States Code, is amended— (A) in subsection (f)— (i) in paragraph (11), by striking ; and and inserting a semicolon; (ii) in paragraph (12), by striking the period and inserting ; and ; and (iii) by adding at the end the following: (13) any member of— (A) the National Science Advisory Board for Biosecurity; (B) the Advisory Committee on Immunization Practices; (C) the Advisory Commission on Childhood Vaccines; (D) the National Vaccine Advisory Committee; (E) the Vaccines and Related Biological Products Advisory Committee; (F) the Defense Science Board; (G) the Board of Scientific Advisors of the National Cancer Institute; (H) the Homeland Security Science and Technology Advisory Committee; (I) the Medical Review Board Advisory Committee; (J) the President’s Council of Advisors on Science and Technology; or (K) any other advisory committee, as defined in section 1001, including a successor to a committee described in this paragraph, that the Government Accountability Office determines, in accordance with subsection (j)— (i) makes recommendations relating to public health to an agency or the President; and (ii) has had any recommendation fully or partially implemented during the 10 years preceding the determination. ; and (B) by adding at the end the following: (j) Determination regarding advisory committees Not later than 180 days after the date of enactment of the Royalty Transparency Act , and annually thereafter, the Government Accountability Office shall publish a list of each advisory committee that the Government Accountability Office determines— (1) makes recommendations relating to public health to an agency or the President